Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
advisor, affirming, antitumor, Canadian, capacity, CDC, chain, combat, constitutional, constitutionality, customary, dismissed, diverge, double, durable, ECDC, excessive, France, Germany, GlaxoSmithKline, gouging, GSK, heard, hygiene, Indian, inflation, instructed, Italy, jointly, led, Modernization, monoclonal, monospecific, onsite, physical, preapproval, presidential, reallocate, reconsider, reexamining, Society, SOX, Spain, subsidiariesw, tiered, undermine, unnecessary, verified
Removed:
accelerate, aggressive, altered, beneficiary, bidding, Blueprint, bulk, calling, cap, carboplatin, certification, codified, communication, consummated, correction, delaying, Document, duly, emerged, encourage, Exhibit, expensed, feedback, Gall, genetic, herewith, Hubei, incentivize, intensified, Linkbase, paclitaxel, passing, pocket, Province, recession, reducing, registrant, remanded, Schema, shared, solicited, Specimen, step, stringent, susceptible, Taxonomy, thereunto, undersigned, Wuhan, XBRL
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view